REGN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regeneron Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Portfolio Pulse from
A class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) for alleged violations of federal securities laws. The lawsuit targets investors who acquired Regeneron securities between November 2, 2023, and October 30, 2024.
March 11, 2025 | 11:15 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Regeneron Pharmaceuticals is facing a class action lawsuit for alleged securities law violations, potentially impacting its stock price.
The lawsuit could lead to financial penalties or settlements, affecting Regeneron's financial standing and investor confidence, likely causing a short-term negative impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100